Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC) is a primary biliary malignancy that harbors a dismal prognosis. Oncogenic mutations of <i>KRAS</i> and loss-of-function mutations of <i>BRCA1-associated protein 1</i> (<i>BAP1</i>) have been identified as recurrent somatic al...
Guardado en:
Autores principales: | Rebecca Marcus, Sammy Ferri-Borgogno, Abdel Hosein, Wai Chin Foo, Bidyut Ghosh, Jun Zhao, Kimal Rajapakshe, James Brugarolas, Anirban Maitra, Sonal Gupta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a62495aad21549c2a67f379c1a441774 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
por: Serifis N, et al.
Publicado: (2021) -
TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma
por: Chen,Yijie, et al.
Publicado: (2015) -
An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
por: He C, et al.
Publicado: (2021) -
Imaging features of intrahepatic cholangiocarcinoma mimicking a liver abscess: an analysis of 8 cases
por: Manrong Liu, et al.
Publicado: (2021) -
Value of Glycogen Synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells
por: Sigen A, et al.
Publicado: (2021)